Literature DB >> 3118094

Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.

U Dührsen1, D Paar, C Kölbel, A Boekstegers, U Metz-Kurschel, R Wagner, W Kirch, P Meusers, E König, G Brittinger.   

Abstract

The clinical and laboratory findings in seven female patients with primary autoimmune diseases, one female patient with lymphoplasmacytoid (LP) immunocytoma and IgM paraproteinemia, and two male patients with multiple myeloma are described. The common denominator in all patients was a lupus anticoagulant or a closely related coagulation disorder. Recurrent thrombosis was observed in six patients with autoimmune diseases and in two patients with malignant monoclonal gammopathies. Other clinical manifestations included cerebral disorders (four patients with autoimmune disease/two patients with monoclonal gammopathy), repeated obstetric complications (6/1), asymptomatic valvular heart disease (6/1), renal dysfunction (6/2), hepatic involvement (2/2), and arthropathy (2/0). Laboratory investigations revealed a biologic false-positive serological test for syphilis in six patients with autoimmune disease and one with monoclonal gammopathy, antinuclear antibodies (4/0), antibodies against DNA (4/1), and a positive direct Coombs test (3/1) which was accompanied by hemolytic anemia in two patients (1/1). Additionally slight leukocytopenia (2/1) and thrombocytopenia (6/2) were observed; abnormal bleeding was only seen in one patient with severe thrombocytopenia. Other complications characteristic of LP immunocytoma or multiple myeloma were missing. The obvious similarities between the patients with autoimmune diseases and the patients with malignant monoclonal gammopathies suggest analogous pathogenetic mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118094     DOI: 10.1007/bf01737004

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Macroglobulinaemia; effect of macroglobulins on prothrombin conversion accelerators.

Authors:  L A LONG; J L RIOPELLE; M FRANCOEUR; A PARE; P POIRIER; M GEORGESCO; G COLPRON
Journal:  Can Med Assoc J       Date:  1955-11-01       Impact factor: 8.262

2.  Autoantibodies to serum lipoproteins.

Authors: 
Journal:  Br Med J       Date:  1972-11-18

3.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

4.  Inhibition of fibrin monomer polymerization by lambda myeloma globulins.

Authors:  M Coleman; E M Vigliano; M E Weksler; R L Nachman
Journal:  Blood       Date:  1972-02       Impact factor: 22.113

5.  Systemic lupus erythematosus with paraproteinemia.

Authors:  L Rubin; M B Urowitz; W Pruzanski
Journal:  Arthritis Rheum       Date:  1984-06

6.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

7.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

8.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

9.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

10.  Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations.

Authors:  G Dighiero; B Guilbert; J P Fermand; P Lymberi; F Danon; S Avrameas
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

View more
  5 in total

1.  Multiple myeloma presenting as mesenteric venous thrombosis and intestinal infarction.

Authors:  Darren A Kastin; John Andrews; Rohit Shah; David Green; John Fryer; Alan L Buchman
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 2.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease.

Authors:  U Dührsen; D Paar; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-01

3.  Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Authors:  M Blank; J Cohen; V Toder; Y Shoenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung.

Authors:  M N Shaukat; P Hughes
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

5.  Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Authors:  E Zuckerman; E Toubi; T D Golan; T Rosenvald-Zuckerman; E Sabo; Z Shmuel; D Yeshurun
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.